Skip to content
Study details
Enrolling now

Geniculate Artery Embolization for Osteoarthritis

University of Minnesota
NCT IDNCT04456569ClinicalTrials.gov data as of Apr 2026
Target enrollment

20

Study length

about 4 years

Ages

40–70

Locations

1 site in MN

About this study

This trial is testing geniculate artery embolization as a treatment for osteoarthritis. This pilot trial will compare geniculate artery embolization to standard of care (physical therapy and oral anti-inflammatory medications) in patients with mild to moderate knee OA. The goal is to determine if embolotherapy can provide sustained symptom control and modify disease progression.

Based on ClinicalTrials.gov records.

What participants do

  • 1.Use Geniculate Artery Embolization
Primary goalSafety as Assessed by Grade 3-4 Adverse events

Participation effort

Estimated from trial records. Details can vary by site.

Time + visits
Low13%
Logistics
Moderate50%

Logistics difficulty varies by site location and availability.

Trial highlights

Treatment details

Auto-extracted from trial records to preview treatments and outcomes.

Endpoints

Primary: Safety as Assessed by Grade 3-4 Adverse events

Secondary: C-Reactive Protein Concentration, IL-6 Concentration

Body systems

Musculoskeletal